community download

EBook: What CROs Must Deliver Orphan Drug Developers

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Specialist trials for rare diseases provide unique challenges to the pharma industry, particularly when it comes to patient recruitment and retention.

By definition, rare disease trials suffer from small numbers of available patients per country and to compound this issue, expert centres to run these trials are few and far between. The rarer the disease, the more significant these challenges become and the greater need for external expertise to overcome development hurdles.

The following pages of this eBook deliver insight into how specialised CRO’s  are providing that external expertise and undertaking clinical research for pharma and biotech companies that are inexperienced when it comes to developing treatments for rare diseases.